Home›People›Michael Cerminaro
MC

Michael Cerminaro

Executive officer and director at Thrombolex.

ExecutiveDirector
Updated Nov 10, 2026·Latest SEC filing Mar 12, 2026·Suggest an edit

About Michael Cerminaro

Michael Cerminaro is an executive officer and director at Thrombolex.

Michael Cerminaro first appears on SEC filings in 2017.

Experience

This experience comes from Michael Cerminaro's profile and from SEC filings. For roles taken from filings, the years are when the filings name Michael Cerminaro in the role, so the role may have started earlier or lasted longer.

Thrombolex, Inc. Current
President & CEO (2016 – Present)
Director
2016 – Present · Kingston, NJ
Thrombolex makes blood clot treatment devices for healthcare professionals.
Deliveright Current
Member Board of Directors
2015 – Present
Cerminaro Group LLC
President & Chief Executive Officer
2013 – 2026
Sound Harbor Partners
Partner & Co-Founder
2009 – 2013
BlackRock, Inc.
Managing Director
2000 – 2008
UBS
Executive Director
1997 – 2000
Bank of America Merrill Lynch
Managing Director
1985 – 1997

Key Colleagues at Startups

The people Michael Cerminaro works with at each company, as listed on that company's latest Form D.

Thrombolex, Inc. · Form D, Mar 12, 2026
DB
David Bonita
Director
KH
PS
Paul Stewart
Director
SL
Sam Liang
Director
MW
Marvin Woodall
Executive officer and director
CD

Sources

  1. SECThrombolex, Inc. Form D, filed Mar 12, 2026